PCI Biotech Holding ASA (PCIB) — Cash Flow-to-Debt Ratio
PCI Biotech Holding ASA (PCIB) has a Cash Flow-to-Debt Ratio of -1.04x as of June 2025, meaning its operating cash flow of Nkr-6.26 Million could theoretically repay -1% of its total liabilities (Nkr6.01 Million) in one year. See PCI Biotech Holding ASA current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PCI Biotech Holding ASA Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for PCI Biotech Holding ASA across 17 annual periods. Also explore PCI Biotech Holding ASA (PCIB) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for PCI Biotech Holding ASA (2008–2024)
Year-by-year debt coverage analysis for PCI Biotech Holding ASA. For market capitalisation and broader financial context, see market cap of PCI Biotech Holding ASA.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.77x | Nkr-13.76 Million | Nkr7.76 Million | ▲ +40.7% |
| 2023 | -2.99x | Nkr-14.97 Million | Nkr5.01 Million | ▲ +69.2% |
| 2022 | -9.71x | Nkr-59.04 Million | Nkr6.08 Million | ▼ -215.5% |
| 2021 | -3.08x | Nkr-68.31 Million | Nkr22.19 Million | ▲ +20.9% |
| 2020 | -3.89x | Nkr-77.39 Million | Nkr19.88 Million | ▼ -26.9% |
| 2019 | -3.07x | Nkr-83.47 Million | Nkr27.20 Million | ▼ -68.8% |
| 2018 | -1.82x | Nkr-31.08 Million | Nkr17.10 Million | ▲ +1.5% |
| 2017 | -1.85x | Nkr-30.62 Million | Nkr16.59 Million | ▲ +51.9% |
| 2016 | -3.83x | Nkr-35.69 Million | Nkr9.31 Million | ▼ -41.4% |
| 2015 | -2.71x | Nkr-32.84 Million | Nkr12.12 Million | ▲ +3.6% |
| 2014 | -2.81x | Nkr-31.67 Million | Nkr11.27 Million | ▲ +8.2% |
| 2013 | -3.06x | Nkr-28.59 Million | Nkr9.34 Million | ▼ -6.8% |
| 2012 | -2.87x | Nkr-24.35 Million | Nkr8.49 Million | ▼ -14.9% |
| 2011 | -2.50x | Nkr-19.05 Million | Nkr7.63 Million | ▼ -114.9% |
| 2010 | -1.16x | Nkr-10.59 Million | Nkr9.12 Million | ▲ +55.5% |
| 2009 | -2.61x | Nkr-16.84 Million | Nkr6.45 Million | ▼ -46.3% |
| 2008 | -1.78x | Nkr-9.41 Million | Nkr5.28 Million | — |